Boehringer Ingelheim News Releases
See the latest Boehringer Ingelheim news releases. To quickly find all news releases on a specific topic, please use the fulltext search.
News Archive
07.05.2008
Women suffering from Decreased Sexual Desire:
Silence hinders diagnosis of the prevalent condition Hypoactive Sexual Desire Disorder(HSDD) For medical media, outside the US only 28.04.2008 European Commission grants full approval of HIV protease inhibitor, tipranavir (Aptivus®) For medical media, outside the US only 25.04.2008 Data suggests promising overall survival and progression-free survival with Vargatef™ (BIBF 1120) For medical media, outside the US only 17.04.2008 New data confirm pramipexole (Mirapexin®/Sifrol®) can significantly reduce sleep disturbance for people with Restless Legs Syndrome (RLS) For medical media, outside the US only 17.04.2008 First ever European Porcine-Circovirus-Research-Award Winners honoured 14.04.2008 New powerful antihypertensive MicardisPlus® 80/25 (80mg telmisartan/25mg hydrochlorothiazide) approved by EU Commission 08.04.2008 Boehringer Ingelheim outpaces the market yet again in 2007
Spiriva®, Micardis® and Flomax® are the major products
A host of compounds in the pipeline from own research and development
31.03.2008 Landmark trial ONTARGET® proves telmisartan is as protective as ramipril and better tolerated in a broad high-risk cardiovascular population.
From ONTARGET® it may be concluded that telmisartan can prevent every 5th serious cardiovascular event. For medical media, outside the US only 27.03.2008 Novel oral anticoagulant Pradaxa® (dabigatran etexilate) approved by the European Commission For medical media, outside the US only 14.02.2008 FDA grants fast track designation for Boehringer Ingelheim’s BIBW 2992 for the treatment of late stage non small cell lung cancer (NSCLC) For medical media, outside the US only
Silence hinders diagnosis of the prevalent condition Hypoactive Sexual Desire Disorder(HSDD) For medical media, outside the US only 28.04.2008 European Commission grants full approval of HIV protease inhibitor, tipranavir (Aptivus®) For medical media, outside the US only 25.04.2008 Data suggests promising overall survival and progression-free survival with Vargatef™ (BIBF 1120) For medical media, outside the US only 17.04.2008 New data confirm pramipexole (Mirapexin®/Sifrol®) can significantly reduce sleep disturbance for people with Restless Legs Syndrome (RLS) For medical media, outside the US only 17.04.2008 First ever European Porcine-Circovirus-Research-Award Winners honoured 14.04.2008 New powerful antihypertensive MicardisPlus® 80/25 (80mg telmisartan/25mg hydrochlorothiazide) approved by EU Commission 08.04.2008 Boehringer Ingelheim outpaces the market yet again in 2007
Spiriva®, Micardis® and Flomax® are the major products
A host of compounds in the pipeline from own research and development
31.03.2008 Landmark trial ONTARGET® proves telmisartan is as protective as ramipril and better tolerated in a broad high-risk cardiovascular population.
From ONTARGET® it may be concluded that telmisartan can prevent every 5th serious cardiovascular event. For medical media, outside the US only 27.03.2008 Novel oral anticoagulant Pradaxa® (dabigatran etexilate) approved by the European Commission For medical media, outside the US only 14.02.2008 FDA grants fast track designation for Boehringer Ingelheim’s BIBW 2992 for the treatment of late stage non small cell lung cancer (NSCLC) For medical media, outside the US only